Ram Naikawadi, PhD
Specialist
Medicine
School of Medicine

Publications (14)

Top publication keywords:
Alveolar Epithelial CellsMicrobiotaUteroglobinPulmonary FibrosisEndothelium, VascularCellular SenescenceCapillary PermeabilityGuanine Nucleotide Exchange FactorsAllograftsVascular Endothelial Growth Factor CTelomereLungIdiopathic Pulmonary FibrosisLymphangiogenesisMitochondria

• Cellular profiling identifies an early profibrotic alveolar type 2 cell signature in lung fibrosis.
  American journal of respiratory and critical care medicine 2026 Naikawadi RP, Bazarov A, Wax Ii M, Boostanpour K, Kukreja J, Traglia M, Agrawal A, Thomas R, Bhattacharya M, Wolters PJ
• Sine oculis homeobox homolog 1 plays a critical role in pulmonary fibrosis.
  JCI insight 2022 Wilson C, Mertens TC, Shivshankar P, Bi W, Collum SD, Wareing N, Ko J, Weng T, Naikawadi RP, Wolters PJ, Maire P, Jyothula SS, Thandavarayan RA, Ren D, Elrod ND, Wagner EJ, Huang HJ, Dickey BF, Ford …
• Invariant Natural Killer T cells coordinate removal of senescent cells.
  Med (New York, N.Y.) 2021 Arora S, Thompson PJ, Wang Y, Bhattacharyya A, Apostolopoulou H, Hatano R, Naikawadi RP, Shah A, Wolters PJ, Koliwad S, Bhattacharya M, Bhushan A
• MAV(S)erick mitochondria: an unconventional role for mitochondrial antiviral signalling protein in pulmonary fibrosis.
  The European respiratory journal 2021 Naikawadi RP, Wolters PJ
• Lymphatic Proliferation Ameliorates Pulmonary Fibrosis after Lung Injury.
  The American journal of pathology 2020 Baluk P, Naikawadi RP, Kim S, Rodriguez F, Choi D, Hong YK, Wolters PJ, McDonald DM

Show all (9 more) Hide

• Airway Epithelial Telomere Dysfunction Drives Remodeling Similar to Chronic Lung Allograft Dysfunction.
  American journal of respiratory cell and molecular biology 2020 Naikawadi RP, Green G, Jones KD, Achtar-Zadeh N, Mieleszko JE, Arnould I, Kukreja J, Greenland JR, Wolters PJ
• Is the microbiome-induced glycolytic pathway a harbinger of acute exacerbation of idiopathic pulmonary fibrosis?
  Thorax 2020 Naikawadi RP
• Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage.
  Nature immunology 2019 Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR, Butte AJ, Bhattacharya M
• Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease.
  Cell 2017 Van Dyken SJ, Liang HE, Naikawadi RP, Woodruff PG, Wolters PJ, Erle DJ, Locksley RM
• Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis.
  JCI insight 2016 Naikawadi RP, Disayabutr S, Mallavia B, Donne ML, Green G, La JL, Rock JR, Looney MR, Wolters PJ
• miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis.
  PloS one 2016 Disayabutr S, Kim EK, Cha SI, Green G, Naikawadi RP, Jones KD, Golden JA, Schroeder A, Matthay MA, Kukreja J, Erle DJ, Collard HR, Wolters PJ
• A critical role for phosphatidylinositol (3,4,5)-trisphosphate-dependent Rac exchanger 1 in endothelial junction disruption and vascular hyperpermeability.
  Circulation research 2012 Naikawadi RP, Cheng N, Vogel SM, Qian F, Wu D, Malik AB, Ye RD
• Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation.
  Molecular pharmacology 2008 Welch EJ, Naikawadi RP, Li Z, Lin P, Ishii S, Shimizu T, Tiruppathi C, Du X, Subbaiah PV, Ye RD
• Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4.
  American journal of physiology. Lung cellular and molecular physiology 2006 Qiao J, Huang F, Naikawadi RP, Kim KS, Said T, Lum H